Edgestream Partners L.P. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 51.3% during the 1st quarter, Holdings Channel.com reports. Get Vertex Pharmaceuticals alerts:Vertex Pharmaceuticals Trading Down 1.3%Shares of VRTX opened at $470.72 on Tuesday. In other Vertex Pharmaceuticals news, EVP Duncan Mckechnie sold 1,541 shares of Vertex Pharmaceuticals stock in a transaction dated Thursday, July 2nd. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report). Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.